trending Market Intelligence /marketintelligence/en/news-insights/trending/okXPbDVagkOiyVN83q250Q2 content esgSubNav
In This List

MacroGenics expands board, adds 2 directors

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


MacroGenics expands board, adds 2 directors

MacroGenics Inc. expanded its board to eight members and appointed Karen Ferrante and Scott Jackson to fill the new vacancies.

Ferrante, who recently served as chief medical officer and head of research and development at Tokai Pharmaceuticals Inc., will serve on the MacroGenics nominating & corporate governance committee. Jackson, who previously served as CEO of Celator Pharmaceuticals Inc., will sit on the compensation committee.